SCHEMBL30773985

SCHEMBL30773985

COc1cccc(S(=O)(=O)N2CC(C(=O)N3CCOc4c(-c5ccc(C#N)cc5)cncc43)C2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP30 Q70CQ3 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ POLB P06746 1/20 0.39
▸ PKM P14618 2/20 0.39
▸ PKLR P30613 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.38
▸ CYP11B1 P15538 2/20 0.38
▸ CYP11B2 P19099 2/20 0.38
▸ TNF P01375 1/20 0.37
▸ NOD1 Q9Y239 1/20 0.37
▸ PAX8 Q06710 1/20 0.37
▸ UCHL1 P09936 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ P2RX7 Q99572 1/20 0.36
▸ LMNA P02545 2/20 0.36
▸ CHRM5 P08912 1/20 0.35
▸ GPR6 P46095 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30774011 0.91 CCR6 (0.44) USP30PKMALDH1A1TNFNOD1
SCHEMBL30774578 0.91 USP30 (0.43) USP30CYP11B1CYP11B2TNFNOD1
SCHEMBL30774412 0.90 PAX8 (0.42) USP30MEN1KMT2APOLBPKM
SCHEMBL30774439 0.89 CHRM1 (0.46) USP30POLBPKMPKLRCYP11B1
SCHEMBL30774802 0.87 USP30 (0.42) USP30PKMPKLRALDH1A1CYP11B1
SCHEMBL30774877 0.86 CYP11B1 (0.40) POLBPKMPKLRCYP11B1CYP11B2
SCHEMBL30773959 0.86 TNFSF11 (0.44) USP30MEN1KMT2AALDH1A1TNF
SCHEMBL30774031 0.85 ABL1 (0.42) USP30ALDH1A1CYP11B1CYP11B2UCHL1
SCHEMBL30774393 0.85 CCR6 (0.41) USP30MEN1KMT2APOLBPKM
SCHEMBL30774900 0.84 TNIK (0.42) USP30MEN1KMT2APOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260092074-A1 Annelated Pyridines as Steroidogenesis Inhibitors, Preparation Method and Use Thereof GUANGZHOU VINNOCENT PHARMACEUTICAL LTD (CN) 2026-04-02 — — US claimed
EP-4574830-A1 ANNELATED PYRIDINE STEROID SYNTHETASE INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF Guangzhou Vinnocent Pharmaceutical Limited (CN) 2025-06-25 — — EP claimed
WO-2024061371-A1 ANNELATED PYRIDINE STEROID SYNTHETASE INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF 广州威诺森医药科技有限公司 2024-03-28 — — WO claimed
US-20260092074-A1 Annelated Pyridines as Steroidogenesis Inhibitors, Preparation Method and Use Thereof GUANGZHOU VINNOCENT PHARMACEUTICAL LTD (CN) 2026-04-02 — — US disclosed
EP-4574830-A1 ANNELATED PYRIDINE STEROID SYNTHETASE INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF Guangzhou Vinnocent Pharmaceutical Limited (CN) 2025-06-25 — — EP disclosed
WO-2024061371-A1 ANNELATED PYRIDINE STEROID SYNTHETASE INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF 广州威诺森医药科技有限公司 2024-03-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260092074-A1 Annelated Pyridines as Steroidogenesis Inhibitors, Preparation Method and Use Thereof STS, NR5A1, CYP21A2 USP30 728/4885MEN1 2219/4885KMT2A 2400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback